Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-025574
Filing Date
2024-08-08
Accepted
2024-08-08 16:25:36
Documents
61
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q eton20240630_10q.htm   iXBRL 10-Q 892741
2 EXHIBIT 31.1 ex_672868.htm EX-31.1 8797
3 EXHIBIT 31.2 ex_672869.htm EX-31.2 8797
4 EXHIBIT 32.1 ex_672870.htm EX-32.1 6429
  Complete submission text file 0001437749-24-025574.txt   5288032

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA eton-20240630.xsd EX-101.SCH 48206
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eton-20240630_cal.xml EX-101.CAL 36230
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eton-20240630_def.xml EX-101.DEF 398485
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE eton-20240630_lab.xml EX-101.LAB 362651
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eton-20240630_pre.xml EX-101.PRE 423449
64 EXTRACTED XBRL INSTANCE DOCUMENT eton20240630_10q_htm.xml XML 614014
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

EIN.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38738 | Film No.: 241188845
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)